Neurology

Neurology clinical trials

Neurology diseases can consist of more than 600 conditions including many rare disorders that affect smaller, underserved patient populations who have access to few, if any, effective treatments.

Neurology drugs also tend to have higher failure rates compared to other therapeutic areas as it can be difficult to generate findings that can be translated into a successful clinical candidate.

Performing clinical trials for neurological diseases then presents a unique set of challenges that can be further complicated by the small size of some study populations.

We can help overcome challenges

Caidya’s experienced team has broad medical and clinical expertise spanning a wide range of therapeutic areas such as neurodegenerative disease, psychiatry, acute and chronic pain and general health conditions meaning we can help overcome these challenges and guide the design of the protocol to the strategy of protocol implementation of your neurology clinical trials.

Our team understands the neurology clinical settings and patient archetypes, connecting you with hospitals and outpatient settings to help you accelerate trial start-up and get the results you need.

We’ve conducted trials for Alzheimer’s, Multiple Sclerosis, Epilepsy, and more – we share the knowledge gathered during these trials of how to find, enroll and keep patients in your study, which is a critical factor to your success.

We cover your entire product lifecycle

With an integrated and personalized service, we cover your entire product lifecycle from clinical development, pre-IND/IND, phase I-III and post-marketing Phase IV studies to NDA submission and pharmacovigilance.

We coordinate all aspects of your program through dedicated project managers, executive sponsorship and innovative monitoring and visual analytics to deliver the highest quality data you need to advance your neurology therapy.